Company: SVV
Filing Date: 2025-05-16
Form Type: 424B5
Source: 0001193125-25-121233
Chunk: 15

Company: Savers Value Village, Inc.
Filing Date: 2025-05-16
Form: 424B5
Chunk 15
---
 authorization of a share repurchase
program of up to $50.0 million of the Company’s common stock. Under the program, we may purchase shares from time to time in compliance with applicable securities laws, that may include Securities Act Rule
10b-18. As of March 29, 2025, we had $6.4 million remaining under the share repurchase program. The program is currently set to expire on November 8, 2025. The Concurrent Share Repurchase will
be funded from our existing cash on hand and is not part of our existing share repurchase program. Although our Board of Directors has authorized the share repurchase program, we are not obligated to repurchase any specific dollar amount or to
acquire any specific number of shares under the program. In addition, the share repurchase program may be suspended, modified, or terminated at any time without prior notice, which may result in a decrease in the price of our common stock. The
amount, timing, and execution of our share repurchase program will be based upon a variety of factors, including the share price of our common stock, general market conditions, alternative uses for capital, our financial performance, and other
considerations. Any repurchases made under the share repurchase program will be funded by available cash and cash equivalents. Even if the share repurchase program is fully implemented, it may not enhance long-term stockholder value, and the program
could affect the price of our common stock, increase volatility, further limit our “public float” and diminish our cash reserves.

If securities or industry analysts either do not publish research about us or publish inaccurate or unfavorable research about us, our business or our market, if they adversely change their recommendations regarding our common stock or if our operating results do not meet their expectations or any financial guidance we may provide, the trading price or trading volume of our common stock could decline.

The trading market for our common stock is influenced in part by the research and reports that securities or
industry analysts may publish about us, our business, our market or our competitors. If one or more of the analysts initiate research with an unfavorable rating or downgrade our common stock, provide a more favorable recommendation regarding our
competitors or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If one or more analysts who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could
lose visibility in the financial markets, which in turn could cause the trading price or